4//SEC Filing
BLISCHAK BRIAN 4
Accession 0001213900-18-005284
CIK 0001416172other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 1:17 PM ET
Size
14.3 KB
Accession
0001213900-18-005284
Insider Transaction Report
Form 4
BLISCHAK BRIAN
Pres./Chief Commercial Officer
Transactions
- Award
COMMON STOCK
2017-09-15$0.63/sh+6,009$3,756→ 12,018 total - Award
OPTIONS
2018-02-28+57,000→ 57,000 totalExercise: $0.76From: 2018-02-28Exp: 2026-02-28→ COMMON STOCK (57,000 underlying) - Award
COMMON STOCK
2017-09-30$0.63/sh+5,934$3,709→ 17,952 total - Award
COMMON STOCK
2017-10-15$0.63/sh+5,934$3,709→ 23,886 total - Award
COMMON STOCK
2017-08-31$0.63/sh+6,009$3,756→ 6,009 total - Award
COMMON STOCK
2017-10-31$0.63/sh+5,934$3,709→ 29,820 total
Footnotes (2)
- [F1]On August 21, 2017, the Company offered to current employees the opportunity to purchase shares of the Company's restricted Common Stock for a discount through payroll deductions. Between August 31, 2017 and October 31, 2017, the Reporting Person acquired 29,820 shares of the Company's restricted common stock through a subscription of the shares as compensation for service as President and Chief Commercial Officer of the Company. These shares were valued at $18,638 ($0.625 per share).
- [F2]On February 28, 2018, and pursuant to the Company's 2016 Ominbus Incentive Plan, the Company granted to the Reporting Person an option (the "Option") to purchase 57,000 shares of the Company's restricted common stock, at a price of $0.76 per share, as compensation for service as President and Chief Commercial Officer of the Company. The term of the Option shall be for a period of eight (8) years from the date of issue. The fair value of the Option was determined to be $12,855 using the Black-Sholes Option Pricing Model. The Option was immediately exercisable at date of issue.
Documents
Issuer
NEXEON MEDSYSTEMS INC
CIK 0001416172
Entity typeother
Related Parties
1- filerCIK 0001693430
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 1:17 PM ET
- Size
- 14.3 KB